Temporary peripheral nerve stimulation
SPRINT PNS
A minimally invasive, drug-free treatment that stimulates a targeted peripheral nerve for up to 60 days—without a permanent implant.
- Up to 60 days
- No permanent implant
- Outpatient lead placement
A temporary approach to neuromodulation
Targeting the nerve involved in pain
Peripheral nerve stimulation sends mild electrical pulses to a nerve outside the brain and spinal cord. SPRINT PNS uses a thin MicroLead placed near the targeted nerve and a small wearable pulse generator.
The treatment is designed for temporary use. The MicroLead is removed after the treatment period rather than remaining as a permanent implant.
A defined treatment period
The system is used for up to 60 days. Some patients notice relief early, while others find that relief develops over several weeks. Results vary.
Many possible nerve targets
Placement is individualized
Your physician selects one or two MicroLeads and the appropriate target based on the location and source of pain.
How SPRINT PNS may provide relief
Rebalancing the signals your brain receives
The manufacturer describes a three-stage concept before, during, and following temporary stimulation.
1
Before treatment
Pain is felt when a nerve sends pain signals to the brain.
2
During treatment
Tiny electrical pulses through the MicroLead are believed to boost non-pain signals and help rebalance the information sent to the brain.
3
Following treatment
The manufacturer states that the brain may no longer respond to pain signals in the same way after the 60-day treatment. Individual results vary.
Three primary components
A small system you control
SPRINT PNS combines a wearable stimulator, wireless remote, and targeted MicroLead.
01 · Wearable
Pulse Generator
A matchbox-sized, battery-powered wearable stimulator that sends gentle electrical pulses through the MicroLead.
02 · Wireless
Hand-Held Remote
A small wireless remote allows the patient to turn stimulation on and off and adjust its intensity.
03 · Targeted
MicroLead
A thin, flexible, threadlike wire—approximately twice the size of a human hair—placed under the skin near the targeted nerve.
Day of the procedure
What to expect
A local anesthetic is used and your physician positions the MicroLead near the targeted nerve using a needle. Your feedback may help locate the desired lead position. A bandage covers the insertion site and the wearable pulse generator connects to the lead.
01
Outpatient placement
A minor procedure places the MicroLead.
02
Local anesthetic
The skin around the site is numbed.
03
Device training
You learn to operate and care for the system.
04
Lead removal
The MicroLead is removed after up to 60 days.
During the treatment period
Living with the system
Your care team will explain activity, site-care, showering, and driving instructions for the treatment period.
Activity
Move with care
Most normal activities may continue, but motion near the lead site is limited for the first seven days and swimming is avoided during treatment.
Care
Keep the site clean
The pulse generator and mounting pad are disconnected for showering. The site should not be submerged, and bandages are changed as instructed.
Driving
Turn stimulation off
Stimulation should be off while driving. Your physician will explain any additional restrictions.
Patient education
Resources
Explore official SPRINT PNS patient resources provided by SPR.
PDF
SPRINT PNS patient brochure
Official overview and frequently asked questions.
Web
Patient videos and app
Official device education from SPR.
A non-permanent option
Could temporary PNS be appropriate for your pain?
A pain specialist can help identify the nerve target and determine whether SPRINT belongs in your treatment plan.
Important safety information
The SPRINT Peripheral Nerve Stimulation (PNS) System is indicated for pain management in adults who have severe intractable chronic pain of peripheral nerve origin, as the sole mitigating agent, or as an adjunct to other modes of therapy used in a multidisciplinary approach. It is intended to be implanted for up to 60 days and provide sustained pain relief for up to three months after treatment ends.
The SPRINT PNS System is not intended to be placed in the region innervated by cranial and facial nerves. Physicians should use their best judgment when deciding when to use the system. The most common adverse events are skin irritation and erythema. Results may vary. Rx only.
SPRINT and SPR are registered trademarks of SPR.